Showing results (351-360 of 377) with videos related to

Sort By:
Pageof 38
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2021
Management of Dyspnea in Advanced Cancer: ASCO GuidelineDavid Hui, Kari Bohlke, Ting Bao, et al.
Gastroenterology|October 4, 2024
Safety and Tolerability of CP101, a Full-Spectrum, Oral Microbiome Therapeutic for the Prevention of Recurrent Clostridioides difficile Infection: A Phase 2 Randomized Controlled TrialJessica R Allegretti, Colleen R Kelly, Thomas Louie, et al.
The Journal of Infectious Diseases|August 2, 2025
Comparability of gastrointestinal microbiome and bile acid profiles in patients with first or multiply recurrent Clostridioides difficile infectionJessica A Bryant, Timothy J Straub, Darrell S Pardi, et al.
JCO Oncology Practice|September 22, 2023
Health Care Contact Days Experienced by Decedents With Advanced GI CancerVishal R Patel, Vidhyalakshmi Ramesh, Alexander K Tsai, et al.
JAMA Network Open|November 27, 2024
Patient, Caregiver, and Clinician Perspectives on the Time Burdens of Cancer CareArjun Gupta, Whitney V Johnson, Nicole L Henderson, et al.
JAMA Oncology|June 13, 2024
Home Time Among Older Adults With Acute Myeloid Leukemia Following ChemotherapyDaniel R Richardson, Xi Zhou, Katherine Reeder-Hayes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 13, 2024
Cannabis and Cannabinoids in Adults With Cancer: ASCO GuidelineIlana M Braun, Kari Bohlke, Donald I Abrams, et al.
North American Spine Society Journal|May 29, 2026
Cluster analysis identifies high-risk phenotypic groups for revision following 1-3 level lumbar fusion in a disadvantaged inner-city populationRegina Golding, Sachin Mehta, Priya Singh, et al.
European Urology Oncology|April 17, 2025
Genetic Drivers of Quality of Life in Prostate Cancer: An Evaluation of Genetic Polymorphisms and Patient-reported Outcomes in the E3805 CHAARTED trialDaniel Sentana-Lledo, Xiangying Chu, Charles J Ryan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2024
Phase I/II Trial of Exportin 1 Inhibitor Selinexor plus Docetaxel in Previously Treated, Advanced KRAS-Mutant Non-Small Cell Lung CancerMitchell S von Itzstein, Timothy F Burns, Jonathan E Dowell, et al.
Pageof 38